A Phase 1, 4-Period, Crossover, Open-label Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Administered as Tablets
Latest Information Update: 29 Jan 2020
At a glance
- Drugs JNJ-64417184 (Primary)
- Indications Respiratory syncytial virus infections
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 27 Jan 2020 Status changed from recruiting to completed.
- 15 Nov 2019 Status changed from not yet recruiting to recruiting.
- 11 Oct 2019 New trial record